Get started
AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsSeasonalsBonds

ABBV chart


Full chart

Key facts today


Piper Sandler has increased the price target for AbbVie (ABBV) to $284.00 per share, up from the previous target of $231.00.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪584.40 T‬ ARS
Dividend yield (indicated)
2.84%
Price to earnings Ratio (TTM)
25
Basic EPS (TTM)
2,175 ARS
Net income (FY)
‪3.88 T‬ ARS
Revenue (FY)
‪51.58 T‬ ARS
Shares float
—
Beta (1Y)
−0.11

About AbbVie Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Robert A. Michael
Website
abbvie.com
Headquarters
North Chicago
Founded
2011
ISIN
ARBCOM4603M9
FIGI
BBG00ZL7CCS3
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Check out other big names from the same industry as ABBV.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ABBV news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ABBV highest yielding bonds


A
ACT4218883
Allergan Funding SCS 4.75% 15-MAR-2045
Yield to maturity
7.00%
Maturity date
Mar 15, 2045
A
ACT3910526
Actavis, Inc. 4.625% 01-OCT-2042
Yield to maturity
6.83%
Maturity date
Oct 1, 2042
A
ACT4176286
Allergan Funding SCS 4.85% 15-JUN-2044
Yield to maturity
6.51%
Maturity date
Jun 15, 2044
XS190919331
Allergan Funding SCS 2.625% 15-NOV-2028
Yield to maturity
5.94%
Maturity date
Nov 15, 2028
ABBV5759196
AbbVie Inc. 5.5% 15-MAR-2064
Yield to maturity
5.52%
Maturity date
Mar 15, 2064
ABBV4911706
AbbVie Inc. 3.2% 21-NOV-2029
Yield to maturity
5.49%
Maturity date
Nov 21, 2029
ABBV6009613
AbbVie Inc. 5.6% 15-MAR-2055
Yield to maturity
5.44%
Maturity date
Mar 15, 2055
ABBV4693583
AbbVie Inc. 4.875% 14-NOV-2048
Yield to maturity
5.41%
Maturity date
Nov 14, 2048
ABBV5759195
AbbVie Inc. 5.4% 15-MAR-2054
Yield to maturity
5.40%
Maturity date
Mar 15, 2054
ABBV5068387
AbbVie Inc. 4.25% 21-NOV-2049
Yield to maturity
5.38%
Maturity date
Nov 21, 2049
US287YAW9
AbbVie Inc. 4.45% 14-MAY-2046
Yield to maturity
5.37%
Maturity date
May 14, 2046

See all ABBV bonds 

Sparks


Curated watchlists where ABBV is featured.

See all sparks